Hydrafacial Launches Advisory Councils to Drive Innovation
Los Angeles, Tuesday, 9 September 2025.
Hydrafacial introduces advisory councils with top experts to enhance product development and clinical excellence, positioning the company for growth in the aesthetic industry.
Unveiling the Hydrafacial Advisory Councils
On 8 September 2025, The Beauty Health Company (NASDAQ: SKIN), the parent company of Hydrafacial, launched its inaugural Hydrafacial Advisory Councils and Ambassador Network. This initiative is designed to enhance product development, education, and clinical excellence by involving top experts in the aesthetic industry, including renowned plastic surgeons, dermatologists, aesthetic practitioners, and estheticians. These councils aim to guide the company’s future innovations and are part of a strategic move to sustain growth in the competitive aesthetic market [1].
Strategic Goals and Expert Leadership
The councils are led by inaugural chairs Ted Lain, MD, MBA; Blaklee Paige Smith, MSN, APRN, AGPCNP-BC, NP-C; and Kelly Horton-Beeman, LE. According to Beauty Health CEO Marla Beck, the councils formalize the company’s commitment to involving healthcare providers in its innovation processes. The Ambassador Network will further champion the brand across digital channels, helping to maintain the company’s market position and public visibility [1].
Hydrafacial’s Market Position and Growth
This development follows The Beauty Health Company’s recent achievements, such as surpassing 35,000 Hydrafacial devices globally. The company’s strategic focus on innovation is evident, with recent financial results showing strong consumer demand for skin health treatments. The establishment of advisory councils is expected to strengthen Hydrafacial’s position within the industry, fostering collaboration and elevating standards [2].
The Role of Innovation in Aesthetic Advancements
As the aesthetic industry becomes increasingly competitive, initiatives like the Hydrafacial Advisory Councils are crucial for maintaining a leadership position. By engaging a diverse group of experts, the company can leverage a wide range of insights to drive product innovation and clinical research. The move is likely to set new benchmarks within the industry, encouraging other companies to adopt similar collaborative approaches [1][2].